Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: increased dizziness, presyncope, exertional angina major surgical or invasive procedure: aortic valve replacement with 21 mm mosaic valve history of present illness: 63 y/o male with known aortic stenosis and single-vessel rca disease which was stented in . recent increase in symptoms. underwent cardiac cath which revealed bicupsod av with severe as. referred for surgical eval. past medical history: aortic stenosis s/p aortic valve replacement coronary artery disease s/p pci hypertension benign prostatic hypertrophy osteoarthritis hemorrhoids remote bilat. ankle fx s/p tonsillectomy s/p r. femoral pseudoaneurysm repair social history: quit smoking after 20 pk/yrs. drinks 1 beer/day family history: noncontributory physical exam: vs: general: nad, fit male heent: eomi, perrl, non-icteric neck: supple, from, -jvd chest: ctab -w/r/r heart: rrr 4/6 sem which radiates to neck abd: soft, nt/nd +bs ext: warm, well-perfused, trace edema, well healed r. fem scar, -varicosities neuro: mae, strengths, non-focal pertinent results: echo: pre-bypass: left ventricular wall thicknesses and cavity size are normal. right ventricular chamber size and free wall motion are normal. there are three aortic valve leaflets. the aortic valve leaflets are severely thickened/deformed. there is severe aortic valve stenosis)area <0.8cm2). the mitral valve leaflets are mildly thickened. mild (1+)mitral regurgitation is seen. there is no pericardial effusion. post-bypass: preserved biventricular function. bioprosthesis is aortic position. well seated and mechamicqally stable. trace ai. no other change cxr: median sternotomy wires are seen. there is atelectasis at the lung bases, new since the previous study. there are no signs of focal consolidation or overt pulmonary edema. cardiac silhouette is upper limits of normal. 11:30am blood wbc-15.4*# rbc-3.67* hgb-11.7* hct-33.4* mcv-91 mc-31.9 mchc-35.1* rdw-13.7 plt ct-147* 05:25am blood wbc-8.2 rbc-3.00* hgb-9.7* hct-27.1* mcv-90 mch-32.2* mchc-35.7* rdw-13.7 plt ct-105* 11:42am blood pt-13.6* ptt-33.5 inr(pt)-1.2* 11:42am blood urean-12 creat-0.7 cl-112* hco3-24 05:25am blood glucose-100 urean-20 creat-0.8 na-136 k-4.3 cl-100 hco3-27 angap-13 brief hospital course: mr. was a same day admit and was brought directly to the or where he underwent an aortic valve replacement. please see surgical report for details. he tolerated the procedure well and was transferred to the csru for invasive monitoring in stable condition. later on op day he was weaned from sedation, awoke neurologically intact and was extubated. on post-op day one he was doing well and was started on beta blockers and diuretics. he was diuresed towards his pre-op weight. also on this day his chest tubes were removed and he was transferred to the telemetry floor. epicardial pacing wires were removed on post-op day two. physical therapy worked with patient for strength and stability. he improved rather fast with no post-op complications and on post-op day three he was discharged home with vna services. medications on admission: terazosin 10mg qd, aspirin 325mg qd, lopid 300mg , mvi, albuterol prn, tylenol 1300mg , amox prn pre dental discharge medications: 1. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 2. furosemide 20 mg tablet sig: one (1) tablet po q12h (every 12 hours). for 7 days 3. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*2* 4. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 5. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed for pain. disp:*60 tablet(s)* refills:*0* potassium chloride 20 meq po bid for 7days gemfibrozil 600mg take half tablet twice daily terazosin 10mg qhs discharge disposition: home with service facility: tba discharge diagnosis: aortic stenosis s/p aortic valve replacement coronary artery disease s/p pci hypertension benign prostatic hypertrophy osteoarthritis hemorrhoids remote bilat. ankle fx s/p tonsillectomy s/p r. femoral pseudoaneurysm repair discharge condition: good discharge instructions: no baths or swimming monitor wounds for infection - redness, drainage, or increased pain report any fever greater than 101 report any weight gain of greater than 2 pounds in 24 hours or 5 pounds in a week no creams, lotions, powders, or ointments to incisions no driving no lifting more than 5 pounds please call with any questions or concerns followup instructions: dr. in 2 weeks () please call for appointment dr in 1 week call for appt dr in 2 weeks call for appt procedure: extracorporeal circulation auxiliary to open heart surgery diagnostic ultrasound of heart open and other replacement of aortic valve with tissue graft diagnoses: coronary atherosclerosis of native coronary artery esophageal reflux pure hypercholesterolemia congestive heart failure, unspecified unspecified essential hypertension aortic valve disorders hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) percutaneous transluminal coronary angioplasty status intestinal disaccharidase deficiencies and disaccharide malabsorption osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh 

Answer: The patient is high likely exposed to